Single-tablet regimens for HIV: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
See also [[HIV treatment]] |
See also [[HIV treatment]] |
||
{| class="wikitable" |
|||
{| |
|||
! Brand name |
! Brand name |
||
! NRTIs |
! NRTIs |
||
Revision as of 14:08, 25 November 2019
See also HIV treatment
| Brand name | NRTIs | Non-NRTI | Notes |
|---|---|---|---|
| Triumeq | abacavir / lamivudine | dolutegravir (INI) | Highest barrier to resistance. Need to test for HLA-B5701 allele before starting. Avoid in hepatitis B coinfection. |
| Atripla | tenofovir disoproxil / emtricitabine | efavirenz | Older regimen. Neuropsychiatric symptoms, possibly including suicide. |
| Complera | tenofovir disoproxil / emtricitabine | rilpivirine | Avoid with viral loads (>100,000) or low CD4 (<200). Pill must be taken with food (>400kcal) and without PPIs. |
| Stribild | tenofovir disoproxil / emtricitabine | elvitegravir/cobicistat (INI) | Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70. |
| Biktarvy | FTC/TAF | BIC |
